Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06113237 · ClinicalTrials.gov registry record
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
A clinical trial of Pregnancy and Maternal Complications, sponsored by Jazz Pharmaceuticals.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06113237 is a study of Pregnancy and Maternal Complications that is actively recruiting participants, run by Jazz Pharmaceuticals. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06113237, a study of Pregnancy and Maternal Complications, is actively recruiting participants, sponsored by Jazz Pharmaceuticals.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
Conditions Studied
Interventions
- DRUG Epidiolex
Study Locations (1)
West Virginia
- United Biosource LLC - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2033-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06113237
The ClinicalTrials.gov registry entry for NCT06113237 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Epidiolex is the first listed.
NCT06113237 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT06113237 about?
NCT06113237 is a clinical study titled "Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy". The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
What is the current status of trial NCT06113237?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-08-05. Estimated completion is 2033-08-31.
What conditions does trial NCT06113237 study?
This clinical trial studies the following conditions: Pregnancy, Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse.
What interventions are being tested in trial NCT06113237?
The interventions under investigation include: Epidiolex (DRUG).
Who is sponsoring clinical trial NCT06113237?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06113237 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.